41 studies found for:    "Leishmaniasis, Visceral"
Show Display Options
Rank Status Study
1 Completed A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.
Conditions: Visceral Leishmaniasis;   Leishmaniasis, Visceral
Intervention: Drug: sitamaquine
2 Completed To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar
Condition: Leishmaniasis, Visceral
Interventions: Drug: Amphotericin B Lipid emulsion;   Drug: Liposomal Amphotericin B
3 Completed Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar
Conditions: Visceral Leishmaniasis;   Kala Azar
Intervention: Device: Long Lasting Impregnated Nets (LLIN)
4 Completed Combination Therapy in Indian Visceral Leishmaniasis
Condition: Leishmaniasis, Visceral
Interventions: Drug: amphotericin B deoxycholate;   Drug: Liposomal Amphotericin B with Miltefosine;   Drug: Liposomal Amphotericin B and Paromomycin Sulfate;   Drug: miltefosine + Paromomycin sulfate
5 Active, not recruiting A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)
Condition: Post-kala-azar Dermal Leishmaniasis
Intervention: Drug: Mitefosine
6 Completed A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar
Condition: Visceral Leishmaniasis
Interventions: Drug: Amphotericin B fat emulsion in visceral leishmaniasis;   Drug: Amphotericin B fat emulsion;   Drug: Amphotericin B in fat emulsion
7 Completed Amphotericin B Treatment in Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: Amphotericin B deoxycholate given as daily administration
8 Completed Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia
Conditions: Visceral Leishmaniasis;   Malnutrition
Intervention:
9 Completed Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: Paromomycin sulfate
10 Completed Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar
Condition: Visceral Leishmaniasis
Intervention: Drug: Liposomal amphotericin B and Miltefosine
11 Completed An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
Condition: Visceral Leishmaniasis
Intervention: Drug: Paromomycin sulfate
12 Completed A Community Trial for Visceral Leishmaniasis (VL)
Condition: Visceral Leishmaniasis
Interventions: Drug: Albendazole, Iron, Zinc and Vitamin A;   Other: Placebo
13 Completed A Pilot Study for Capacity Building for a Multi-centre, Randomized Trial for Treatment of Kala Azar in Bangladesh
Condition: Visceral Leishmaniasis
Intervention: Drug: Randomized trial for treatment of kala azar in Bangladesh
14 Completed Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Interventions: Drug: Liposomal Amphotericin B;   Drug: amphotericin B deoxycholate
15 Not yet recruiting Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: AMBISOME
16 Completed Combination Chemotherapy for the Treatment of Indian Kala-Azar
Condition: Visceral Leishmaniasis
Intervention: Drug: Combination therapy with AmBisome and miltefosine
17 Completed Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
Condition: Visceral Leishmaniasis
Interventions: Drug: Meglumine antimoniate;   Drug: Amphotericin B-deoxycholate
18 Terminated Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
Condition: Visceral Leishmaniasis
Interventions: Drug: Antimoniate of N-methylglucamine;   Drug: amphotericin B deoxycholate;   Drug: Liposomal amphotericin B
19 Completed An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: Paromomycin
20 Unknown  Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
Conditions: Visceral Leishmaniasis;   Immune Response;   Treatment
Interventions: Drug: N-acetylcysteine;   Drug: Pentavalent antimonial

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years